RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 10 analysts with an average price target of $30.69. This is a potential upside of $21.75 (243.29%) from yesterday's end of day stock price of $8.94.

Arcus Biosciences's activity chart (see below) currently has 75 price targets and 90 ratings on display. The stock rating distribution of RCUS is 82.05% BUY and 17.95% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.29% with an average time for these price targets to be met of 194.29 days.

Highest price target for RCUS is $46, Lowest price target is $14, average price target is $35.33.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 23-Apr-2025. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 32 are a BUY (82.05%), 7 are a HOLD (17.95%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

$4.88 (53.51%)

$29

13 days ago
(23-Apr-2025)

3/8 (37.5%)

$5.89 (72.63%)

108

Hold

$24

$14.88 (163.16%)

$18

2 months 10 days ago
(26-Feb-2025)

0/4 (0%)

$13.76 (134.38%)

Hold

$17

$7.88 (86.40%)

$23

2 months 17 days ago
(19-Feb-2025)

2/4 (50%)

$5.9 (53.15%)

14

Buy

$25

$15.88 (174.12%)

$36

2 months 18 days ago
(18-Feb-2025)

0/6 (0%)

$11.9 (90.84%)

Buy

$46

$36.88 (404.39%)

$38

6 months 12 days ago
(24-Oct-2024)

2/12 (16.67%)

$28.17 (157.99%)

294

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 194.29 days on average for the stock forecasts to be realized with a an average price target met ratio 24.29

Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Robert Driscoll works at WEDBUSH and has 17 price targets and 9 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with highest potential upside - $50.9

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Geoffrey Porges with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?